Hi everybody!
Well, this might be our most long-awaited episode yet. It covers the topic of our currently most active thread, which has been viewed over half a million times. We mean of course Neuromod's Lenire treatment. Check out the ongoing discussion about it here.
It's an extra-long episode, because so many questions were raised on our forum about Lenire – the thread has been viewed over half a million times – that we felt we needed to do our best to gather as many answers as possible.
In the episode, Hazel and Ross talk about the basic principles of the treatment, its effectiveness, and risks. We also covered clinical trial results and go in-depth on what the treatment actually looks like. We clarify whom Lenire is suitable for, and Ross makes some projections about future roll-out of the device.
Listen on:
- Tinnitus Talk Podcast (incl. timestamps and transcript)
- SoundCloud
- iTunes
- Spotify
We welcome any discussion, but please keep the following in mind when commenting:
- Off-topic comments, i.e. not directly responding to the content of the podcast, will be removed. So please do listen before commenting!
- While we welcome constructive criticism on ideas or policies, we do not tolerate direct attacks on individuals.
Tinnitus Talk would like to thank Neuromod for its continued cooperation with us, and for providing the tinnitus community with this chance to engage directly with them.
This episode was produced, as usual, by @Markku and @Hazel. Do you want to join our team as well? Let us know!
Don't forget to:
Sharing Is Caring
Share the podcast on your social media and with your tinnitus friends!